ELLENNBE
LIVE

Serial Number

79345349

Owner

ellennbe GmbH

Attorney

GABRIELLE S. ROTH

Filing Date

Feb 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ELLENNBE Trademark

Serial Number: 79345349 • Registration: 7601776

ELLENNBE is a trademark filed by ellennbe GmbH on February 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

ellennbe GmbH

Stallauer-Berg-Weg 11

Entity Type: 99

Lydia Ellen Neumann

Stallauer-Berg-Weg 11

Entity Type: 98

Dr. Barbara Lösch

Mooswiesenstr. 11c

Entity Type: 98

Trademark Details

Filing Date

February 25, 2022

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Licensing of patents; granting of licenses to others for the use of industrial property rights and copyright; licensing of intellectual property; licensing of patents, computer software and intellectual property in the field of technology

Hypodermic injection apparatus, namely, hypodermic syringes and hypodermic needles filled with immunomodulatory drugs or peripheral blood mononuclear cells

Research and development of vaccines and medicines; bacteriological research and analysis; biological research, clinical research, namely, medical and scientific research in the nature of conducting clinical trials for others, and medical research; pharmaceutical products development; biological research; biochemical analysis; biological analysis; laboratory research services relating to dermatology; pharmaceutical drug development services; research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development of new products; research and development services in the field of antibodies; research relating to biotechnology; research to develop new products; biological research and analysis; biomedical research services; design and product development of medical technology; design and development of medical technology, namely, software design and development for medical technology; scientific research in the field of pharmacy; product development of pharmaceutical preparations and medicines; pharmaceutical research services; biotechnological research relating to livestock, namely, research in the field of gene editing technology and biological research in the field of livestock; pharmaceutical research and development; bacteriological analysis; medical research; development of new products; biochemical research and analysis; research on the subject of pharmaceuticals; biological analysis in the field of molecular biology; none of the foregoing services related to lasers, laser medicine, or laser medical research

Dressings, medical; adhesive skin patches for medical use; heating patches for medical purposes; adhesive plasters for medical purposes; pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the treatment of autoimmune disorders and autoimmune diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 6, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 19, 2025 FICS
FINAL DISPOSITION PROCESSED
May 19, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 27, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 27, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 27, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 14, 2024 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 13, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 27, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 27, 2023 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 9, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 9, 2023 GNSL
SUSPENSION LETTER WRITTEN
Aug 9, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 2, 2023 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 19, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 19, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 19, 2023 COAR
REFUSAL PROCESSED BY IB
Mar 6, 2023 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2023 NREP
CHANGE OF OWNER RECEIVED FROM IB
Feb 11, 2023 CHLD
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 14, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 13, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 21, 2022 REPR